Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2014
02/27/2014US20140056846 Treating Hepatitis C Virus Infection
02/27/2014US20140056844 Methods of metabolic targeting cancer cells using chemo- and immunotherapy for treating cancer
02/27/2014US20140056841 Compositions and Methods for Promoting the Healing of Tissue of Multicellular Organisms
02/27/2014US20140056831 Treatment and Reduction in Incidence of Skin Cancer
02/27/2014US20140056828 Novel formulations and uses for curcuma extracts
02/27/2014US20140056823 Combinations of medicaments for the treatment of respiratory diseases
02/27/2014US20140056817 Photodynamic therapy or diagnostic agent, using infrared-spectrum light
02/27/2014DE60000133C5 Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen Essential fatty acids for the prevention of cardiovascular attacks
02/27/2014DE10322191B4 N-sulfonylierte Aminosäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung N-sulfonylated amino acid derivatives, processes for their preparation and their use
02/27/2014CA2876690A1 Dihydropyrimidine compounds and their application in pharmaceuticals
02/27/2014CA2876543A1 Pyrrolo[2,3-b]pyrazines as syk inhibitors
02/26/2014EP2700643A1 Tetrahydrothiazepine derivative
02/26/2014EP2700642A1 Camptothecin compound containing stable 7-membered lactone ring, preparation method and use
02/26/2014EP2700639A1 Selective ligands for the neuronal nicotinic receptors and uses thereof
02/26/2014EP2700638A1 Purine analogs
02/26/2014EP2700627A1 Method for producing complex crystal and method for screening complex crystal
02/26/2014EP2700421A1 Immobilized biologically active entities having a high degree of biological activity
02/26/2014EP2700414A1 Self-gelatinizable nucleic acid
02/26/2014EP2700413A1 Composition comprising dihydroquercetin, alpha-tocopherol and bisabolol
02/26/2014EP2700409A1 IL-27 for modulation of immune response in acute lung disease
02/26/2014EP2700407A1 Granules in liquid dosage form
02/26/2014EP2700406A1 METHOD FOR PRODUCING POLYGONUM TINCTORIUM EXTRACT& xA;
02/26/2014EP2700404A1 Antcin derivatives in combination with an anti-cancer drug in treatment and/or prevention of tumors
02/26/2014EP2700403A1 Therapeutic agent for tumor
02/26/2014EP2700402A2 Novel uses of licochalcone a
02/26/2014EP2700401A1 Method for producing adhesive patch, and adhesive patch
02/26/2014EP2700400A1 Controlled release formulation with continuous efficacy
02/26/2014EP2700398A1 Effervescent Sachet Formulations of Dapoxetine and a Pde5 Inhibitor
02/26/2014EP2700397A1 Effervescent Tablet Formulations of Dapoxetine and a Pde5 Inhibitor
02/26/2014EP2700321A1 Aqueous food composition enriched in beta-glucan
02/26/2014EP2699696A2 Molecular subtyping, prognosis and treatment of prostate cancer
02/26/2014EP2699677A1 Protein for use as a medicament
02/26/2014EP2699673A2 Recombinant virus products and methods for inhibition of expression of myotilin
02/26/2014EP2699581A1 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives
02/26/2014EP2699579A1 Pyrazolo [4, 3-d]pyrimidines useful as kinase inhibitors
02/26/2014EP2699578A1 Fluoroalkyl-substituted pyrazolopyridines and use thereof
02/26/2014EP2699577A1 Tetrahydropyrazolo [1,5 -a]pyrimidine as anti -tuberculosis compounds
02/26/2014EP2699576A1 Pyrazolospiroketone derivatives for use as acetyl - coa carboxylase inhibitors
02/26/2014EP2699575A1 Triazolopyridines
02/26/2014EP2699574A1 Bicyclic heterocycle compounds and their uses in therapy
02/26/2014EP2699573A2 7-(3,5-dimethyl-4-isoxazolyl)-8-(methyloxy)-1h-imidazo[4,5-c]quinoline derivatives
02/26/2014EP2699572A1 Heterocyclic compounds as kinase inhibitors
02/26/2014EP2699570A1 1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof
02/26/2014EP2699569A2 Aminopyrimidine kinase inhibitors
02/26/2014EP2699568A1 A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation
02/26/2014EP2699567A1 Insulin-like growth factor-1 receptor inhibitors
02/26/2014EP2699566A1 Phenyl-isoxazol derivatives and preparation process thereof
02/26/2014EP2699565A1 Fatty acid amide hydrolase inhibitors for treating pain
02/26/2014EP2699564A1 Substituted pyrimidinyl-pyrroles active as kinase inhibitors
02/26/2014EP2699561A1 Androgen receptor modulating carboxamides
02/26/2014EP2699560A2 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof
02/26/2014EP2699559A1 Dibenzothiazepine derivatives and their use in the treatment of cns disorders
02/26/2014EP2699558A1 Benzothiazole compounds and their pharmaceutical use
02/26/2014EP2699557A1 Aromatic amides and uses thereof
02/26/2014EP2699554A1 Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
02/26/2014EP2699552A1 Multicomponent crystalline system of rosuvastatin calcium salt and vanillin
02/26/2014EP2699551A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
02/26/2014EP2699550A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
02/26/2014EP2699549A1 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
02/26/2014EP2699547A1 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/ 2-pyrimidine-carborxamides as mglur5 modulators
02/26/2014EP2699545A1 Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
02/26/2014EP2699543A1 Novel modulators of cortical dopaminergic- and nmda-receptor-mediated glutamatergic neurotransmission
02/26/2014EP2699539A2 Cyclopropyl derivatives and methods of use
02/26/2014EP2699327A1 Method for purification of micafungin
02/26/2014EP2699319A1 Niclosamide for the treatment of cancer metastasis
02/26/2014EP2699250A2 Composition and method for enhancing an immune response
02/26/2014EP2699249A1 Cartilage product
02/26/2014EP2699247A1 Method for combined conditioning and chemoselection in a single cycle
02/26/2014EP2699246A1 Method of inhibiting harmful microorganisms and barrier-forming composition therefor
02/26/2014EP2699245A1 Hair loss treatment
02/26/2014EP2699244A1 Method for modulating cytokine activity
02/26/2014EP2699243A1 Prostacyclin and analogs thereof administered during surgery for prevention and treatment of capillary leakage
02/26/2014EP2699242A2 Carbon monoxide releasing molecules and uses thereof
02/26/2014EP2699241A1 Antiviral compounds
02/26/2014EP2699240A2 Acadesine derivatives, products and compositions including same, therapeutic uses thereof, and methods for synthesizing same
02/26/2014EP2699239A2 Medical products for use in conditions related to microbial infections in the upper aerodigestive tract
02/26/2014EP2699238A2 Antiviral compositions directed against the influenza virus nucleoprotein
02/26/2014EP2699237A2 Therapy for leukemia
02/26/2014EP2699236A1 Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (ndga)
02/26/2014EP2699233A1 A method for the treatment of a solid tumour
02/26/2014EP2699218A1 Use of a combination of carotenoid, phytoestrogen and vitamin c for the prevention and/or treatment of pigmentation disorders
02/26/2014EP2699113A1 Nutritional compositions having alpha-hica and eicosapentaenoic acid
02/26/2014EP2699112A1 Nutritional compositions having alpha-hica and citrulline
02/26/2014EP2699111A1 Nutritional compositions comprising alpha-hydroxyisocaproic acid
02/26/2014EP2699110A1 Nutritional compositions having alpha-hica and alpha-ketoglutarate
02/26/2014EP2699109A1 Prebiotic carbohydrate compositions
02/26/2014EP2699105A1 Beadlets comprising carotenoids
02/26/2014EP2699099A1 Chewing gum comprising chitosan for use in reduction of the level of free phosphorus compounds in the digestive juice
02/26/2014EP2699094A1 Taste-masked formulations of raltegravir
02/26/2014EP2699091A1 2',6'-dioxo-3'-deutero-piperdin-3-yl-isoindoline compounds
02/26/2014CN103608456A Use of aptamers in therapy and/or diagnosis of autoimmune diseases
02/26/2014CN103608350A Triazolopyridine compounds
02/26/2014CN103608349A Solid forms and salts of tetrahydro-pyrido-pyrimidine derivatives
02/26/2014CN103608348A Crystal of fused heterocyclic compound
02/26/2014CN103608347A 咪唑并吡啶化合物 Imidazopyridine compound
02/26/2014CN103608346A Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase
02/26/2014CN103608345A Oxazine derivative and BACE 1 inhibitor containing same
02/26/2014CN103608344A [1,3]oxazines
02/26/2014CN103608343A Crystalline forms and processes for preparation of condensed azacycles (cannabinoid receptor modulators)
02/26/2014CN103608342A Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
1 ... 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 ... 7860